Publication | Closed Access

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

Cluster HeadacheMedicinePharmacotherapyAcute MigraineNeurologyParallel-treatment TrialPharmacologyNew Oral AntagonistDrug Discovery